Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro (Q39138015)

9 September 2017

Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro (English)

1 reference

9 September 2017

multiple drug resistance

1 reference

Farong Li

1

1 reference

9 September 2017

Jufang Fan

2

1 reference

9 September 2017

Zhen Wu

3

1 reference

9 September 2017

Rui Yuan Liu

4

1 reference

9 September 2017

Ling Guo

5

1 reference

9 September 2017

Zhongmin Dong

6

1 reference

9 September 2017

Zhezhi Wang

7

1 reference

9 September 2017

19 June 2013

1 reference

9 September 2017

Pharmaceutical Biology

1 reference

9 September 2017

51

1 reference

9 September 2017

9

1 reference

9 September 2017

1196-1203

1 reference

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

9 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Strategies for reversing drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

ABC-transporters: implications on drug resistance from microorganisms to human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Multidrug resistance: molecular mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Effective two-dimensional counter-current chromatographic method for simultaneous isolation and purification of oridonin and ponicidin from the crude extract of Rabdosia rubescens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Rapid assessment of P-glycoprotein inhibition and induction in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Screening for peptide drugs from the natural repertoire of biodiverse protein folds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13880209.2013.784342

10.3109/13880209.2013.784342

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference